Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11752198 GLP-1 compositions and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 8, 2020
Date of Patent
September 12, 2023
Patent Application Number
17115773
Patent Citations
‌
US Patent 7112567 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
‌
US Patent 8129343 Acylated GLP-1 compounds
‌
US Patent 8158583 Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
‌
US Patent RE43834 Injection syringe
‌
US Patent 8541470 Topical pharmaceutical formulation
‌
US Patent 8846618 Stable formulation of modified GLP-1
‌
US Patent 9133276 Prodrugs comprising an exendin linker conjugate
‌
US Patent 9217022 GLP-1 receptor agonist compounds having stabilized regions
‌
US Patent 9265723 Long acting insulin composition
‌
US Patent 9457066 Prodrugs comprising an insulin linker conjugate
•••
Patent Inventor Names
Joakim Lundqvist
Michael Duelund Soerensen
Eva Horn Moeller
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11752198
Patent Primary Examiner
‌
Sudhakar Katakam
CPC Code
‌
A61K 47/10
‌
A61K 9/0019
‌
A61K 38/26
‌
A61K 47/02
‌
A61K 9/08

Find more entities like US Patent 11752198 GLP-1 compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo